Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The correlation between discrepancies in clinical and pathological T stages and overall survival in upper urinary tract urothelial carcinoma: Analysis of the hospital-based cancer registry data in Japan.
Shiga M, Nagumo Y, Kojo K, Kandori S, Takahashi R, Isoda B, Suzuki S, Hamada K, Tanuma K, Nitta S, Hoshi A, Negoro H, Mathis BJ, Okuyama A, Nishiyama H. Shiga M, et al. Among authors: kandori s. Int J Urol. 2025 Jan 3. doi: 10.1111/iju.15665. Online ahead of print. Int J Urol. 2025. PMID: 39749844
Variations in the diagnostic performance of transurethral resection of bladder tumor with photodynamic diagnosis according to surgical experience: A retrospective, single-center study.
Suzuki S, Nagumo Y, Kojo K, Ikeda A, Isoda B, Yamaguchi A, Tanuma K, Nitta S, Shiga M, Kawahara T, Kandori S, Hoshi A, Negoro H, Mathis BJ, Nishiyama H. Suzuki S, et al. Among authors: kandori s. Photodiagnosis Photodyn Ther. 2024 Dec 3;51:104429. doi: 10.1016/j.pdpdt.2024.104429. Online ahead of print. Photodiagnosis Photodyn Ther. 2024. PMID: 39638220 Free article.
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T. Mori K, et al. Among authors: kandori s. Cancer Sci. 2024 Nov 17. doi: 10.1111/cas.16326. Online ahead of print. Cancer Sci. 2024. PMID: 39550694 Free article.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan.
Takahashi R, Nitta S, Kandori S, Suzuki S, Hamada K, Tanuma K, Kojo K, Shiga M, Sakka S, Nagumo Y, Mathis BJ, Hoshi A, Negoro H, Okuyama A, Higashi T, Nishiyama H. Takahashi R, et al. Among authors: kandori s. Int J Clin Oncol. 2024 Nov;29(11):1756-1761. doi: 10.1007/s10147-024-02607-y. Epub 2024 Sep 5. Int J Clin Oncol. 2024. PMID: 39235705
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.
Isoda B, Kandori S, Sazuka T, Kojima T, Nitta S, Shiga M, Nagumo Y, Fujimoto A, Arai T, Sato H, Mathis BJ, Wu CL, Jan YH, Ichikawa T, Nishiyama H. Isoda B, et al. Among authors: kandori s. Int J Mol Sci. 2024 Jul 6;25(13):7444. doi: 10.3390/ijms25137444. Int J Mol Sci. 2024. PMID: 39000552 Free PMC article.
97 results